Delaware Health News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Health News Online.

Press releases published on August 14, 2026

Aug. 14, 2026

BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base

Indeterminate GlobeNewswire

Aug. 14, 2026

Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Aug. 14, 2026

Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™

Indeterminate GlobeNewswire

Aug. 14, 2026

Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 14, 2026

Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update 

Indeterminate GlobeNewswire

Aug. 14, 2026

 Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress

Indeterminate GlobeNewswire

Aug. 14, 2026

Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis

Indeterminate GlobeNewswire

Aug. 14, 2026

Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences

Indeterminate GlobeNewswire

Aug. 14, 2026

Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 14, 2026

Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Indeterminate GlobeNewswire

Aug. 14, 2026

Pfizer et Valneva annoncent l’acceptation pour revue par l’Agence européenne des médicaments (EMA) de la demande d’autorisation de mise sur le marché de leur candidat vaccin contre la maladie de Lyme

Indeterminate GlobeNewswire

Aug. 14, 2026

Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering

Indeterminate GlobeNewswire

Aug. 14, 2026

More Cancer Patients Are Opting to Preserve Their Tumors

Indeterminate GlobeNewswire

Aug. 14, 2026

Nutraville Announces MemoryFuel Launch as Interest Grows Around Creatine Monohydrate, Brain Energy, and Daily Mental Performance

Indeterminate GlobeNewswire